Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-April Through June 2022, 47751-47765 [2022-16717]

Download as PDF 47751 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection jspears on DSK121TN23PROD with NOTICES 1. Type of Information Collection Request: Extension of a currently approved collection; Title: Hospital Wage Index Occupational Mix Survey; Use: Section 304(c) of Public Law 106– 554 amended section 1886(d)(3)(E) of the Social Security Act to require CMS to collect data every 3 years on the occupational mix of employees for each short-term, acute care hospital participating in the Medicare program, in order to construct an occupational mix adjustment to the wage index, for application beginning October 1, 2004 (the FY 2005 wage index). The purpose of the occupational mix adjustment is to control for the effect of hospitals’ employment choices on the wage index. For example, hospitals may choose to employ different combinations of registered nurses, licensed practical nurses, nursing aides, and medical assistants for the purpose of providing nursing care to their patients. The varying labor costs associated with these choices reflect hospital management decisions rather than geographic differences in the costs of labor. CMS takes the data collected from the approximately 3,200 IPPS providers participating in the Medicare program and runs the data through mathematical formulas to create the occupational mix adjustment to the wage index. CMS informs hospitals of the occupational mix adjusted wage indexes through notice and comment rulemaking each year. Form Number: CMS–10079 (OMB Control Number: 0938–0907); Frequency: Annually; Affected Public: Private Sector, Business or other forprofit and not-for-profit institutions; Number of Respondents: 3,200; Number of Responses: 3,200; Total Annual Hours: 1,536,000. (For policy questions regarding this collection contact Noel Manlove at 410–786–5161.) 2. Type of Information Collection Request: Reinstatement, with change, of a previously approved collection for which approval has expired; Title: Basic Health Program (BHP) Supporting Regulations; Use: In accordance with Section 1331 of the Patient Protection and Affordability Care Act, Public Law 111–148 (ACA), BHP is federally funded by determining the amount of payments that the federal government would have made through premium tax credits and cost-sharing reductions for people enrolled in BHP had they instead been enrolled in an Exchange. States must submit a BHP Blueprint to CMS for certification prior to the state implementing a BHP and must submit a revised Blueprint in the event that a state seeks to make significant changes that alter program operations; the BHP benefit package; or enrollment, disenrollment, and verification policies described in the Blueprint. Such States must also submit a BHP annual report. In addition to the reinstatement, this 2022 iteration proposes changes that are associated with the March 12, 2014 (79 FR 14112) BHP final rule that have not previously received PRA approval; Form Number: CMS–10510 (OMB Control Number: 0938–1218); Frequency: Monthly and annually; Affected Public: State, Local or Tribal Government; Number of Respondents: 2; Number of Responses: 27; Total Annual Hours: 2,568. (For policy questions regarding this collection contact Cassie Lagorio at 443–721–8022.) Dated: July 29, 2022. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2022–16681 Filed 8–3–22; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–9137–N] Medicare and Medicaid Programs; Quarterly Listing of Program Issuances—April Through June 2022 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This quarterly notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from April through June 2022, relating to the Medicare and Medicaid programs and other programs administered by CMS. FOR FURTHER INFORMATION CONTACT: It is possible that an interested party may need specific information and not be able to determine from the listed information whether the issuance or regulation would fulfill that need. Consequently, we are providing contact persons to answer general questions concerning each of the addenda published in this notice. SUMMARY: Addenda Contact I CMS Manual Instructions ..................................................................................... II Regulation Documents Published in the Federal Register ............................... III CMS Rulings ...................................................................................................... IV Medicare National Coverage Determinations ................................................... V FDA-Approved Category B IDEs ........................................................................ VI Collections of Information .................................................................................. VII Medicare-Approved Carotid Stent Facilities ..................................................... VIII American College of Cardiology—National Cardiovascular Data Registry Sites. IX Medicare’s Active Coverage-Related Guidance Documents ............................ X One-time Notices Regarding National Coverage Provisions ............................. XI National Oncologic Positron Emission Tomography Registry Sites ................. XII Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities. XIII Medicare-Approved Lung Volume Reduction Surgery Facilities .................... XIV Medicare-Approved Bariatric Surgery Facilities .............................................. XV Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials ...... Ismael Torres .......................................... Terri Plumb ............................................. Tiffany Lafferty ........................................ Wanda Belle, MPA ................................. John Manlove ......................................... William Parham ...................................... Sarah Fulton, MHS ................................. Sarah Fulton, MHS ................................. (410) 786–1864 (410) 786–4481 (410)786–7548 (410) 786–7491 (410) 786–6877 (410) 786–4669 (410) 786–2749 (410) 786–2749 JoAnna Baldwin, MS .............................. JoAnna Baldwin, MS .............................. David Dolan, MBA .................................. David Dolan, MBA .................................. (410) (410) (410) (410) Sarah Fulton, MHS ................................. Sarah Fulton, MHS ................................. David Dolan, MBA .................................. (410) 786–2749 (410) 786–2749 (410) 786–3365 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1 Phone No. 786–7205 786–7205 786–3365 786–3365 47752 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices Addenda Contact All Other Information ................................................................................................ Annette Brewer ....................................... SUPPLEMENTARY INFORMATION: jspears on DSK121TN23PROD with NOTICES I. Background The Centers for Medicare & Medicaid Services (CMS) is responsible for administering the Medicare and Medicaid programs and coordination and oversight of private health insurance. Administration and oversight of these programs involves the following: (1) furnishing information to Medicare and Medicaid beneficiaries, health care providers, and the public; and (2) maintaining effective communications with CMS regional offices, state governments, state Medicaid agencies, state survey agencies, various providers of health care, all Medicare contractors that process claims and pay bills, National Association of Insurance Commissioners (NAIC), health insurers, and other stakeholders. To implement the various statutes on which the programs are based, we issue regulations under the authority granted to the Secretary of the Department of Health and Human Services under sections 1102, 1871, 1902, and related provisions of the Social Security Act (the Act) and Public Health Service Act. We also issue various manuals, memoranda, and statements necessary to administer and oversee the programs efficiently. VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 Section 1871(c) of the Act requires that we publish a list of all Medicare manual instructions, interpretive rules, statements of policy, and guidelines of general applicability not issued as regulations at least every 3 months in the Federal Register. II. Format for the Quarterly Issuance Notices This quarterly notice provides only the specific updates that have occurred in the 3-month period along with a hyperlink to the full listing that is available on the CMS website or the appropriate data registries that are used as our resources. This is the most current up-to-date information and will be available earlier than we publish our quarterly notice. We believe the website list provides more timely access for beneficiaries, providers, and suppliers. We also believe the website offers a more convenient tool for the public to find the full list of qualified providers for these specific services and offers more flexibility and ‘‘real time’’ accessibility. In addition, many of the websites have listservs; that is, the public can subscribe and receive immediate notification of any updates to the website. These listservs avoid the need to check the website, as notification of updates is automatic and PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Phone No. (410) 786–6580 sent to the subscriber as they occur. If assessing a website proves to be difficult, the contact person listed can provide information. III. How To Use the Notice This notice is organized into 15 addenda so that a reader may access the subjects published during the quarter covered by the notice to determine whether any are of particular interest. We expect this notice to be used in concert with previously published notices. Those unfamiliar with a description of our Medicare manuals should view the manuals at https:// www.cms.gov/manuals. The Director of the Office of Strategic Operations and Regulatory Affairs of the Centers for Medicare & Medicaid Services (CMS), Kathleen Cantwell, having reviewed and approved this document, authorizes Trenesha FultzMimms, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Dated: July 28, 2022. Trenesha Fultz-Mimms, Federal Register Liaison, Department of Health and Human Services. BILLING CODE 4120–01–P E:\FR\FM\04AUN1.SGM 04AUN1 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47753 EN04AU22.000</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.001</GPH> jspears on DSK121TN23PROD with NOTICES 47754 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47755 EN04AU22.002</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.003</GPH> jspears on DSK121TN23PROD with NOTICES 47756 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47757 EN04AU22.004</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.005</GPH> jspears on DSK121TN23PROD with NOTICES 47758 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47759 EN04AU22.006</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.007</GPH> jspears on DSK121TN23PROD with NOTICES 47760 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47761 EN04AU22.008</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.009</GPH> jspears on DSK121TN23PROD with NOTICES 47762 VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4725 E:\FR\FM\04AUN1.SGM 04AUN1 47763 EN04AU22.010</GPH> jspears on DSK121TN23PROD with NOTICES Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices VerDate Sep<11>2014 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices 17:25 Aug 03, 2022 Jkt 256001 PO 00000 Frm 00076 Fmt 4703 Sfmt 9990 E:\FR\FM\04AUN1.SGM 04AUN1 EN04AU22.011</GPH> jspears on DSK121TN23PROD with NOTICES 47764 Federal Register / Vol. 87, No. 149 / Thursday, August 4, 2022 / Notices [FR Doc. 2022–16717 Filed 8–3–22; 8:45 am] BILLING CODE 4120–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0297] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Production, Storage and Transportation of Shell Eggs (Preventing Salmonella Enteritidis (SE)) AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Submit written comments (including recommendations) on the collection of information by September 6, 2022. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be submitted to https:// www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under Review—Open for Public Comments’’ or by using the search function. The OMB control number for this information collection is 0910–0660. Also include the FDA docket number found in brackets in the heading of this document. SUMMARY: FOR FURTHER INFORMATION CONTACT: Rachel Showalter, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 240–994–7399, PRAStaff@ fda.hhs.gov. In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. jspears on DSK121TN23PROD with NOTICES SUPPLEMENTARY INFORMATION: Production, Storage and Transportation of Shell Eggs (Preventing Salmonella Enteritidis (SE)) OMB Control Number 0910–0660— Extension—21 CFR 118.10 and 118.11 This information collection supports Agency regulations in part 118 (21 CFR VerDate Sep<11>2014 17:25 Aug 03, 2022 Jkt 256001 part 118), Production, Storage, and Transportation of Shell Eggs, and Form FDA 3733, Shell Egg Producer Registration Form. The Public Health Service Act (PHS Act) (42 U.S.C. 264) authorizes the Secretary of Health and Human Services to make and enforce such regulations as ‘‘are necessary to prevent the introduction, transmission, or spread of communicable diseases from foreign countries into the States . . . or from one State . . . into any other State’’ (section 361(a) of the PHS Act (42 U.S.C. 264(a))). This authority has been delegated to the Commissioner of Food and Drugs. Under section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 342(a)(4)), a food is adulterated if it is prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth or rendered injurious to health. Under section 701(a) of the FD&C Act (21 U.S.C. 371(a)), FDA is authorized to issue regulations for the efficient enforcement of the FD&C Act. Under part 118, shell egg producers are required to implement measures to prevent SE from contaminating eggs on the farm and from further growth during storage and transportation. Shell egg producers also are required to maintain records concerning their compliance with part 118 and to register with FDA. As described in more detail about each information collection provision of part 118, each farm site with 3,000 or more egg laying hens that sells raw shell eggs to the table egg market, other than directly to the consumer, must refrigerate, register, and keep certain records. Farms that do not send all their eggs to treatment are also required to have an SE prevention plan and to test for SE. Section 118.10 of FDA’s regulations requires recordkeeping for all measures the farm takes to prevent SE in its flocks. Since many existing farms participate in voluntary egg quality assurance programs, those respondents may not have to collect any additional information. Records are maintained on file at each farm site and examined there periodically by FDA inspectors. Section 118.10 also requires each farm site with 3,000 or more egg laying hens that sells raw shell eggs to the table egg market, other than directly to the consumer, and does not have all of the shell eggs treated, to design and implement an SE prevention plan. Section 118.10 requires recordkeeping for each of the provisions included in the plan and for plan review and modifications if corrective actions are taken. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 47765 Finally, § 118.11 of FDA’s regulations requires that each farm covered by § 118.1(a) register with FDA using Form FDA 3733. The term ‘‘Form FDA 3733’’ refers to both the paper version of the form and the electronic system known as the Shell Egg Producer Registration Module, which is available at https:// www.access.fda.gov. We strongly encourage electronic registration because it is faster and more convenient. The system can accept electronic registrations 24 hours a day, 7 days a week. A registering shell egg producer receives confirmation of electronic registration instantaneously once all the required fields on the registration screen are completed. However, paper registrations will also be accepted. Form FDA 3733 is available for download for registration by mail, fax, or CD–ROM. For more information, we invite you to visit our websites at: https:// www.fda.gov/food/registration-foodfacilities-and-other-submissions/shellegg-producer-registration and https:// www.fda.gov/Food/ GuidanceRegulation/ FoodFacilityRegistration/ ShellEggProducerRegistration/ ucm217952.htm. Recordkeeping and registration are necessary for the success of the SE prevention measures. Written SE prevention plans and records of actions taken due to each provision are essential for farms to implement SE prevention plans effectively. Further, they are essential for us to be able to determine compliance. Information provided under these regulations helps us to quickly notify the facilities that might be affected by a deliberate or accidental contamination of the food supply. In addition, data collected through registration is used to support our enforcement activities. Description of Respondents: Respondents to this information collection include farm sites with 3,000 or more egg laying hens that sell raw eggs to the table egg market, other than directly to the consumer. In the Federal Register of January 19, 2022 (87 FR 2797), FDA published a 60day notice requesting public comment on the proposed collection of information. Two comments were received, however only one was responsive to the four information collection topics solicited. The comment suggested that farms could save money by pooling samples while conducting environmental testing, proffering a 2015 research article. FDA reviewed the 2015 research article by Kinde et al. and had additional questions about the equivalency of pooled versus non-pooled samples. This E:\FR\FM\04AUN1.SGM 04AUN1

Agencies

[Federal Register Volume 87, Number 149 (Thursday, August 4, 2022)]
[Notices]
[Pages 47751-47765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16717]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-9137-N]


Medicare and Medicaid Programs; Quarterly Listing of Program 
Issuances--April Through June 2022

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This quarterly notice lists CMS manual instructions, 
substantive and interpretive regulations, and other Federal Register 
notices that were published from April through June 2022, relating to 
the Medicare and Medicaid programs and other programs administered by 
CMS.

FOR FURTHER INFORMATION CONTACT: It is possible that an interested 
party may need specific information and not be able to determine from 
the listed information whether the issuance or regulation would fulfill 
that need. Consequently, we are providing contact persons to answer 
general questions concerning each of the addenda published in this 
notice.

------------------------------------------------------------------------
             Addenda                    Contact            Phone No.
------------------------------------------------------------------------
I CMS Manual Instructions.......  Ismael Torres......     (410) 786-1864
II Regulation Documents           Terri Plumb........     (410) 786-4481
 Published in the Federal
 Register.
III CMS Rulings.................  Tiffany Lafferty...      (410)786-7548
IV Medicare National Coverage     Wanda Belle, MPA...     (410) 786-7491
 Determinations.
V FDA-Approved Category B IDEs..  John Manlove.......     (410) 786-6877
VI Collections of Information...  William Parham.....     (410) 786-4669
VII Medicare-Approved Carotid     Sarah Fulton, MHS..     (410) 786-2749
 Stent Facilities.
VIII American College of          Sarah Fulton, MHS..     (410) 786-2749
 Cardiology--National
 Cardiovascular Data Registry
 Sites.
IX Medicare's Active Coverage-    JoAnna Baldwin, MS.     (410) 786-7205
 Related Guidance Documents.
X One-time Notices Regarding      JoAnna Baldwin, MS.     (410) 786-7205
 National Coverage Provisions.
XI National Oncologic Positron    David Dolan, MBA...     (410) 786-3365
 Emission Tomography Registry
 Sites.
XII Medicare-Approved             David Dolan, MBA...     (410) 786-3365
 Ventricular Assist Device
 (Destination Therapy)
 Facilities.
XIII Medicare-Approved Lung       Sarah Fulton, MHS..     (410) 786-2749
 Volume Reduction Surgery
 Facilities.
XIV Medicare-Approved Bariatric   Sarah Fulton, MHS..     (410) 786-2749
 Surgery Facilities.
XV Fluorodeoxyglucose Positron    David Dolan, MBA...     (410) 786-3365
 Emission Tomography for
 Dementia Trials.

[[Page 47752]]

 
All Other Information...........  Annette Brewer.....     (410) 786-6580
------------------------------------------------------------------------


SUPPLEMENTARY INFORMATION:

I. Background

    The Centers for Medicare & Medicaid Services (CMS) is responsible 
for administering the Medicare and Medicaid programs and coordination 
and oversight of private health insurance. Administration and oversight 
of these programs involves the following: (1) furnishing information to 
Medicare and Medicaid beneficiaries, health care providers, and the 
public; and (2) maintaining effective communications with CMS regional 
offices, state governments, state Medicaid agencies, state survey 
agencies, various providers of health care, all Medicare contractors 
that process claims and pay bills, National Association of Insurance 
Commissioners (NAIC), health insurers, and other stakeholders. To 
implement the various statutes on which the programs are based, we 
issue regulations under the authority granted to the Secretary of the 
Department of Health and Human Services under sections 1102, 1871, 
1902, and related provisions of the Social Security Act (the Act) and 
Public Health Service Act. We also issue various manuals, memoranda, 
and statements necessary to administer and oversee the programs 
efficiently.
    Section 1871(c) of the Act requires that we publish a list of all 
Medicare manual instructions, interpretive rules, statements of policy, 
and guidelines of general applicability not issued as regulations at 
least every 3 months in the Federal Register.

II. Format for the Quarterly Issuance Notices

    This quarterly notice provides only the specific updates that have 
occurred in the 3-month period along with a hyperlink to the full 
listing that is available on the CMS website or the appropriate data 
registries that are used as our resources. This is the most current up-
to-date information and will be available earlier than we publish our 
quarterly notice. We believe the website list provides more timely 
access for beneficiaries, providers, and suppliers. We also believe the 
website offers a more convenient tool for the public to find the full 
list of qualified providers for these specific services and offers more 
flexibility and ``real time'' accessibility. In addition, many of the 
websites have listservs; that is, the public can subscribe and receive 
immediate notification of any updates to the website. These listservs 
avoid the need to check the website, as notification of updates is 
automatic and sent to the subscriber as they occur. If assessing a 
website proves to be difficult, the contact person listed can provide 
information.

III. How To Use the Notice

    This notice is organized into 15 addenda so that a reader may 
access the subjects published during the quarter covered by the notice 
to determine whether any are of particular interest. We expect this 
notice to be used in concert with previously published notices. Those 
unfamiliar with a description of our Medicare manuals should view the 
manuals at https://www.cms.gov/manuals.
    The Director of the Office of Strategic Operations and Regulatory 
Affairs of the Centers for Medicare & Medicaid Services (CMS), Kathleen 
Cantwell, having reviewed and approved this document, authorizes 
Trenesha Fultz-Mimms, who is the Federal Register Liaison, to 
electronically sign this document for purposes of publication in the 
Federal Register.

    Dated: July 28, 2022.
Trenesha Fultz-Mimms,
Federal Register Liaison, Department of Health and Human Services.
BILLING CODE 4120-01-P

[[Page 47753]]

[GRAPHIC] [TIFF OMITTED] TN04AU22.000


[[Page 47754]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.001


[[Page 47755]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.002


[[Page 47756]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.003


[[Page 47757]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.004


[[Page 47758]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.005


[[Page 47759]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.006


[[Page 47760]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.007


[[Page 47761]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.008


[[Page 47762]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.009


[[Page 47763]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.010


[[Page 47764]]


[GRAPHIC] [TIFF OMITTED] TN04AU22.011


[[Page 47765]]


[FR Doc. 2022-16717 Filed 8-3-22; 8:45 am]
BILLING CODE 4120-01-C
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.